(Q35981594)

11 August 2017

Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide (English)

1 reference

11 August 2017

C A Bill

1

1 reference

11 August 2017

C M Vines

2

1 reference

11 August 2017

K C Garrett

3

1 reference

11 August 2017

K Yamada

4

1 reference

11 August 2017

P J Tofilon

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

61

1 reference

11 August 2017

4

1 reference

11 August 2017

563-567

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.126

11 August 2017

0 references

cites work

The radioresponsiveness of human tumours and the initial slope of the cell survival curve

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Polar solvents: a novel class of antineoplastic agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Cell kinetics and radiation biology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

A new group of potent inducers of differentiation in murine erythroleukemia cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

A molecular theory of cell survival.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971349

Modification of tumor and normal tissue radioresponse in mice by N-methylformamide

24 September 2018

1 reference

12 December 2020

Radiosensitization of primary human tumor cell cultures by N-methylformamide

1 reference

12 December 2020

Chromatin modifications associated with N-methylformamide-induced radiosensitization of clone A cells

1 reference

12 December 2020

Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide

1 reference

12 December 2020

Automatic processing and interpretation of DNA distributions: comparison of several techniques

1 reference

12 December 2020

Alteration of the survival response of two human colon carcinoma subpopulations to x-irradiation by N,N-dimethylformamide

1 reference

12 December 2020

Effects of hexamethylene bisacetamide onα-fetoprotein, albumin, and transferrin production by two rat hepatoma cell lines

1 reference

12 December 2020

Studies of the pharmacology of N-methylformamide in mice

1 reference

12 December 2020

Induced cell differentiation in cancer therapy

1 reference

12 December 2020

Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.126

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

2331442

1 reference